Literature DB >> 16135639

Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia.

Ellen S Herbener1, S Kristian Hill, Robert W Marvin, John A Sweeney.   

Abstract

OBJECTIVE: The authors evaluated emotion perception in acutely ill patients experiencing a first episode of schizophrenia. They also investigated the effects of antipsychotic medication on emotion perception.
METHOD: Tests of the ability to perceive and discriminate emotional expressions from the Penn Computerized Neuropsychological Battery were given to 13 patients experiencing their first episode of schizophrenia. Patients were also assessed with the Positive and Negative Syndrome Scale. The patients were tested while they were unmedicated and again following clinical stabilization. Healthy individuals were evaluated over a similar time interval.
RESULTS: Patients with first-episode schizophrenia demonstrated impairments in emotion perception before treatment and no significant improvement after treatment. Emotion perception deficits were correlated with negative symptoms after clinical stabilization.
CONCLUSIONS: Deficits in emotion perception are present at illness onset in schizophrenia and show minimal response to effective antipsychotic treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135639     DOI: 10.1176/appi.ajp.162.9.1746

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  31 in total

1.  Assessment of social judgments and complex mental states in the early phases of psychosis.

Authors:  Shannon M Couture; David L Penn; Jean Addington; Scott W Woods; Diana O Perkins
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

2.  Facial emotion recognition in first-episode schizophrenia and bipolar disorder with psychosis.

Authors:  Alexander R Daros; Anthony C Ruocco; James L Reilly; Margret S H Harris; John A Sweeney
Journal:  Schizophr Res       Date:  2014-01-21       Impact factor: 4.939

3.  The effect of emotional context on facial emotion ratings in schizophrenia.

Authors:  Yu Sun Chung; Deanna M Barch
Journal:  Schizophr Res       Date:  2011-06-29       Impact factor: 4.939

4.  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

Review 5.  [Expression, identification and experience of emotions in mental diseases. An overview].

Authors:  K Wolf; R Maß; M Lambert; K Wiedemann; D Naber
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

6.  Extraction of social information from gait in schizophrenia.

Authors:  J S Peterman; A Christensen; M A Giese; S Park
Journal:  Psychol Med       Date:  2013-06-28       Impact factor: 7.723

7.  The Change in Facial Emotion Recognition Ability in Inpatients with Treatment Resistant Schizophrenia After Electroconvulsive Therapy.

Authors:  Mihriban Dalkıran; Akif Tasdemir; Tamer Salihoglu; Murat Emul; Alaattin Duran; Mufit Ugur; Ruhi Yavuz
Journal:  Psychiatr Q       Date:  2017-09

8.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

9.  Cognitive neurosciences: A new paradigm in management and outcome of schizophrenia.

Authors:  Amresh K Shrivastava; Megan E Johnston
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

10.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.